Literature DB >> 16489649

Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis.

Chang-Ping Wu1, Jing-Ting Jiang, Min Tan, Yi-Bei Zhu, Mei Ji, Kuan-Feng Xu, Jie-Min Zhao, Guang-Bo Zhang, Xue-Guang Zhang.   

Abstract

AIM: To investigate the expression of co-stimulatory molecule B7-H3 in gastric carcinoma and adenoma tissue as well as normal gastric tissue and to explore the relationship between B7-H3 expression and pathological features and prognosis of gastric carcinoma.
METHODS: B7-H3 expression was detected in 102 samples of human gastric carcinoma and 10 samples of gastric adenoma and 10 samples of normal gastric tissue by immunohistochemical assay. Correlation between the expression of B7-H3 and the patients' age, sex, gastric carcinoma locus, tumor size, tissue type, tumor infiltration depth, differentiation degree, lymph node metastasis, and survival time was analyzed.
RESULTS: B7-H3 was expressed in all gastric adenoma samples and in 58.8% samples of gastric carcinoma. B7-H3 expression in gastric carcinoma samples was not related with the patients' age, sex, lymph node metastasis, and tumor size (P>0.05), but with the survival time, infiltration depth of tumor and tissue type.
CONCLUSION: Detection of B7-H3 expression in gastric carcinoma tissue is beneficial to the judgment of the prognosis of gastric carcinoma patients and the choice of treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489649      PMCID: PMC4066068          DOI: 10.3748/wjg.v12.i3.457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

Review 2.  Spinning molecular immunology into successful immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

3.  Mouse B7-H3 induces antitumor immunity.

Authors:  X Sun; M Vale; E Leung; J R Kanwar; R Gupta; G W Krissansen
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

4.  Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

Authors:  Peter Steinberger; Otto Majdic; Sophia V Derdak; Katharina Pfistershammer; Stefanie Kirchberger; Christoph Klauser; Gerhard Zlabinger; Winfried F Pickl; Johannes Stöckl; Walter Knapp
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

5.  Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.

Authors:  Marina K Ayrapetov; Sungsoo Lee; Gongqin Sun
Journal:  Protein Expr Purif       Date:  2003-06       Impact factor: 1.650

6.  The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.

Authors:  Woong-Kyung Suh; Beata U Gajewska; Hitoshi Okada; Matthew A Gronski; Edward M Bertram; Wojciech Dawicki; Gordon S Duncan; Jacob Bukczynski; Suzanne Plyte; Andrew Elia; Andrew Wakeham; Annick Itie; Stephen Chung; Joan Da Costa; Sudha Arya; Tom Horan; Pauline Campbell; Kevin Gaida; Pamela S Ohashi; Tania H Watts; Steven K Yoshinaga; Mark R Bray; Manel Jordana; Tak W Mak
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

7.  Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.

Authors:  Vincent Ling; Paul W Wu; Vikki Spaulding; Jan Kieleczawa; Deborah Luxenberg; Beatriz M Carreno; Mary Collins
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

8.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

  8 in total
  67 in total

1.  Inhibitors of B7-CD28 costimulation in urologic malignancies.

Authors:  R Houston Thompson; Eugene D Kwon; James P Allison
Journal:  Immunotherapy       Date:  2009-01       Impact factor: 4.196

Review 2.  T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.

Authors:  Yael S Barach; Jun Sik Lee; Xingxing Zang
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

3.  B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.

Authors:  Phyu P Aung; Edwin Roger Parra; Souptik Barua; Dawen Sui; Jing Ning; Barbara Mino; Debora Alejandra Ledesma; Jonathan L Curry; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Eleni Efstathiou; Anh G Hoang; Michael K Wong; Jennifer A Wargo; Alexander J Lazar; Arvind Rao; Victor G Prieto; Ignacio Wistuba; Michael T Tetzlaff
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

Review 4.  Inhibitory costimulation and anti-tumor immunity.

Authors:  Natalia Martin-Orozco; Chen Dong
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

5.  A novel monoclonal antibody against mouse B7-H3 developed in rats.

Authors:  Ruhong Yan; Shun Yang; Jing Sun; Xuqin Chen; Guangbo Zhang; Ping Feng; Xueguang Zhang
Journal:  Hybridoma (Larchmt)       Date:  2012-08

6.  B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.

Authors:  Liang Lin; Li Cao; Yang Liu; Ke Wang; Xinwei Zhang; Xiaodan Qin; Dandan Zhao; Jie Hao; Yingjun Chang; Xiaojun Huang; Bei Liu; Jun Zhang; Jin Lu; Qing Ge
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

7.  High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.

Authors:  Zhili Xu; Ling Wang; Jianhua Tian; Hongwei Man; Pengfei Li; Baoen Shan
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

Review 8.  B7-h3 and its role in antitumor immunity.

Authors:  Martin Loos; Dennis M Hedderich; Helmut Friess; Jörg Kleeff
Journal:  Clin Dev Immunol       Date:  2010-11-28

9.  Clinical importance of B7-H3 expression in human pancreatic cancer.

Authors:  I Yamato; M Sho; T Nomi; T Akahori; K Shimada; K Hotta; H Kanehiro; N Konishi; H Yagita; Y Nakajima
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.

Authors:  Martin Loos; Dennis M Hedderich; Malte Ottenhausen; Nathalia A Giese; Melanie Laschinger; Irene Esposito; Jörg Kleeff; Helmut Friess
Journal:  BMC Cancer       Date:  2009-12-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.